-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Neutral on 10x Genomics, Raises Price Target to $47

Benzinga·08/10/2026 18:37:52
Listen to the news
Piper Sandler analyst David Westenberg maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $42 to $47.